Inflammation and acute brain injuries in intensive care;Inflammation et lésions cérébrales aiguës en anesthésie réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue 12, 2008, Pages 1008-1015

  Degos, V ^a,b,c   Teissier, N ^a,b   Gressens, P ^a,b   Puybasset, L ^c   Mantz, J ^a,b,d  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d BEAUJON HOSPITAL   (France)

Author keywords

Acute brain injuries; Excitotoxicity; Inflammation; Neuroinflammation; Neuroprotection

Indexed keywords

ANESTHETIC AGENT; CHEMOKINE; CYTOKINE; GLUCOCORTICOID; MATRIX METALLOPROTEINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ASTROCYTE; BRAIN DAMAGE; BRAIN INJURY; CELL TYPE; ENCEPHALITIS; EXCITOTOXICITY; INTENSIVE CARE; LEUKOCYTE; MICROGLIA; MODULATION; NEUROPROTECTION; SHORT SURVEY;

ACUTE DISEASE; ANESTHETICS; BRAIN INJURIES; ENCEPHALITIS; HUMANS; INTENSIVE CARE;

EID: 57249088907     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2008.07.099     Document Type: Short Survey

References (49)

1. Shalak L., and Perlman J.M. Hypoxic-ischemic brain injury in the term infant-current concepts. Early Hum Dev 80 (2004) 125-141
2. Hagberg H. Mitochondrial impairment in the developing brain after hypoxia-ischemia. J Bioenerg Biomembr 36 (2004) 369-373
3. Hallenbeck J.M. Significance of the inflammatory response in brain ischemia. Acta Neurochir Suppl 66 (1996) 27-31
4. Chopp M., Li Y., Jiang N., Zhang R.L., and Prostak J. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 16 (1996) 578-584
5. Yenari M.A., Kunis D., Sun G.H., Onley D., Watson L., Turner S., et al. Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp Neurol 153 (1998) 223-233
6. Becker K., Kindrick D., Relton J., Harlan J., and Winn R. Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32 (2001) 206-211
7. Vemuganti R., Dempsey R.J., and Bowen K.K. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke 35 (2004) 179-184
8. Jiang N., Moyle M., Soule H.R., Rote W.E., and Chopp M. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol 38 (1995) 935-942
9. Wood P.L. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 17 (1995) 242-248
10. Beschorner R., Schluesener H.J., Gozalan F., Meyermann R., and Schwab J.M. Infiltrating CD14+ monocytes and expression of CD14 by activated parenchymal microglia/macrophages contribute to the pool of CD14+ cells in ischemic brain lesions. J Neuroimmunol 126 (2002) 107-115
11. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225
12. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96 (1999) 13496-13500
13. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
14. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
15. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2 (2001) 734-744
16. Basu A., Lazovic J., Krady J.K., Mauger D.T., Rothstein R.P., Smith M.B., et al. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J Cereb Blood Flow Metab 25 (2005) 17-29
17. Haqqani A.S., Nesic M., Preston E., Baumann E., Kelly J., and Stanimirovic D. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 19 (2005) 1809-1821
18. Garau A., Bertini R., Colotta F., Casilli F., Bigini P., Cagnotto A., et al. Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30 (2005) 125-131
19. Chen Y., Hallenbeck J.M., Ruetzler C., Bol D., Thomas K., Berman N.E., et al. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23 (2003) 748-755
20. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R., et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125 (2002) 59-65
21. Stamatovic S.M., Shakui P., Keep R.F., Moore B.B., Kunkel S.L., Van Rooijen N., et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25 (2005) 593-606
22. Sugimoto K., and Iadecola C. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia. Brain Res 960 (2003) 273-276
23. Iadecola C., Zhang F., and Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268 (1995) R286-R292
24. Han H.S., Qiao Y., Karabiyikoglu M., Giffard R.G., and Yenari M.A. Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci 22 (2002) 3921-3928
25. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893 (2001) 104-112
26. Lee S.R., Kim H.Y., Rogowska J., Zhao B.Q., Bhide P., Parent J.M., et al. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci 26 (2006) 3491-3495
27. Favrais G., Schwendimann L., Gressens P., and Lelievre V. Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-beta on excitotoxic brain lesions in newborn mice. Neurobiol Dis 25 (2007) 496-505
28. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007) 289-296
29. Buller K.M., Xu Y., and Day T.A. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1 beta. J Neuroendocrinol 10 (1998) 519-528
30. Thornton P., Pinteaux E., Gibson R.M., Allan S.M., and Rothwell N.J. Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J Neurochem 98 (2006) 258-266
31. Giaume C., Froger N., and Koulakoff A. Communication jonctionnelle entre astrocytes et neuroprotection. Ann Fr Anesth Reanim 24 (2005) 695-696
32. Raivich G., Bohatschek M., Kloss C.U., Werner A., Jones L.L., and Kreutzberg G.W. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30 (1999) 77-105
33. Kirsch J.R., Traystman R.J., and Hurn P.D. Anesthetics and cerebroprotection: experimental aspects. Int Anesthesiol Clin 34 (1996) 73-93
34. Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314 (1986) 397-403
35. Mantz J. Effets neuroprotecteurs des agents anesthésiques. Ann Fr Anesth Reanim 18 (1999) 588-592
36. Bhardwaj A., and Kirsch J.R. Anesthetic agents and hypothermia in ischemic brain protection. Anesthesiology 89 (1998) 289-291
37. Sano T., Drummond J.C., Patel P.M., Grafe M.R., Watson J.C., and Cole D.J. A comparison of the cerebral protective effects of isoflurane and mild hypothermia in a model of incomplete forebrain ischemia in the rat. Anesthesiology 76 (1992) 221-228
38. Miyazaki H., Nakamura Y., Arai T., and Kataoka K. Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 86 (1997) 1359-1366 [discussion 8A]
39. Albanèse J., Garnier F., Bourgoin A., and Leone M. Les agents utilisés pour la sédation en neuro-réanimation. Ann Fr Anesth Reanim 23 (2004) 528-534
40. Nishina K., Akamatsu H., Mikawa K., Shiga M., Maekawa N., Obara H., et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 86 (1998) 159-165
41. Chen R.M., Chen T.G., Chen T.L., Lin L.L., Chang C.C., Chang H.C., and Wu C.H. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci 1042 (2005) 262-271
42. Gomes J.A., Stevens R.D., Lewin III J.J., Mirski M.A., and Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Crit Care Med 33 (2005) 1214-1224
43. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364 (2004) 1321-1328
44. Lescot T., Marchand-Verrecchia C., and Puybasset L. Stratégies anti-inflammatoires et traumatisme crânien. Ann Fr Anesth Reanim 25 (2006) 755-760
45. Garcia J.H., Liu K.F., and Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147 (1995) 1477-1486
46. Loddick S.A., and Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16 (1996) 932-940
47. Pinteaux E., Rothwell N.J., and Boutin H. Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53 (2006) 551-556
48. Hutchinson P.J., O'Connell M.T., Rothwell N.J., Hopkins S.J., Nortje J., Carpenter K.L., et al. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 24 (2007) 1545-1557
49. Clark S.R., McMahon C.J., Gueorguieva I., Rowland M., Scarth S., Georgiou R., et al. Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations. J Cereb Blood Flow Metab (2007)